TABLE 1
FROM:
The role of leptin in anorexia nervosa: clinical implications
J Hebebrand, T D Muller, K Holtkamp and B Herpertz-Dahlmann
BACK TO ARTICLETable 1. Synopsis of selected studies related to leptin in AN patients and other samples comprised of individuals with low fat mass (a complete overview of all studies related to leptin secretion in patients with AN is available from the authors)
| Ref. | Subjects (n) | Mean age in years (range) |
Mean BMI s.d. (range)
|
Mean leptin levels ( g/l) (range)
| Point in time of blood sampling | Correlation leptin: BMI (leptin: % body fat) | Detection |
|---|---|---|---|---|---|---|---|
| 27 | AN (n=15; one male) | 19.9 (14–32) | 13.8 (11.6–17.2) | <1 (n=10 including n=4 undetectable) 1–4 (n=5) | During in-patient treatment | No clear relation | ELISA |
| 18 | AN (n=23) | 15.8 (13.1–18.6) | 14.4 (12.4–17.3) | (0.04–1.69; n=18) | Within the first days upon referral | r=0.48; n=18 | Self-devised RIA |
| 118 | AN (n=33) | 22.8 6 | 15.7 1.6 | 1.9 1.8 | Between 0800 and 0900 after an overnight fast | Not significant | Self-devised RIA |
| 19 | AN (n=11) | 24 6 | 13.5 1.2 | 1.75 0.46 | After an overnight fast; at the end of a 3-week nutritional stabilization phase | Not significant | Linco Research |
| 28 | AN (n=22) | 23 4 (18–32) | 16.3 1.6 | 5.6 3.7 | After an overnight fast |
r=0.60 (r=0.63) | Linco Research |
| 61 | AN (n=23) | 16.2 0.3* (12.2–18.8) | 16.7 0.2*
| 4.3 0.6*
| In the fasted state at a baseline visit |
r=0.59 (r=0.81) | Linco Research |
| 120 | AN (n=20) | 22.1 1 | 13.7 0.4*
| 1.7 0.1*
| While fasting |
r=0.780 (r=0.805) | Linco Research |
| 119 | AN (n=20a) AN (n=23b) | 15.5 1.6 16.2 1.6 | 17.0 1.1 16.2 0.9 | 3.3 2.1 3.1 2.4 | In the fasting state at an initial visit | ND | Linco Research |
| 39 | AN (n=57) | 25.0 7.0 (16–49) | 15.2 1.5 | 2.3 1.6 | At referral after an overnight fast | (r=0.57c, d) | Linco Research |
| 121 | AN (n=18) | 23.0 5.6 | 14.2 2.3 | 2.5 0.9 | At baseline after an overnight fast |
r=0.34; n=13 (r=0.65; n=13) | Linco Research |
| 73 | AN (n=18) | 14.1 1.2 | 14.4 1.2 | 1.9 1.2 | After an overnight fast on day 7 of the 1st week of in-patient treatment | ND | Mediagnost |
| 99 | AN (n=61; group 1) AN (n=27; group 2) | 17.5 4.6 (12.0–31.4) 14.5 1.3 (11.5–17.4) | 14.5 1.5 (10.5–17.4) 14.5 1.3 (12.3–17.5) | 0.9 1.4 (0.004–7.4) 1.8 1.1 (0.5–4.6) | At referral, after an overnight fast within 3 days upon admission |
r=0.484c (group 1) [r=0.691c (group 1)] | Mediagnost |
| 46 | Undernourished Gambian children (n=472; 251 male) | 8.01 0.69 (male) 8.00 0.68 (female) | 14.0 1.01 13.89 1.04 | 1.83 0.48 (0.97–3.47) 2.36 0.91 (0.86–9.31) | At the morning after an overnight fast | Leptin positively associated with BMI and body fat for age z-score (P 0.0001) | Linco Research |
| 48 | Ache Amerindians (n=12) | 32.2 14.0 | 25.2 1.9 | 5.6 3.2 | After their morning meal | ND | Linco Research |
| 44 | AN (n=9) Underweight women (n=7) | 17.2 0.9 23.3 3.1 | 14.6 0.4 15.7 0.4 | Undectectable (<2) Significantly higher than in AN patients (P>0.05) | After minimum weight gain of 10% At different times at the menstrual cycle | ND ND | Nichols Diagnostics |
Abbreviations: AN, anorexia nervosa; BMD, bone mineral density; BMI, body mass index; BN, bulimia nervosa; ELISA, enzyme-linked immunosorbent assay; ND, not determined; Ref., reference; RIA, radioimmunoassay.
* s.e.m.
a BMD z-score
-1.
b BMD z-score <-1.
c Log leptin.
d Fat mass.

s.d. (range)
g/l) (range)
0.0001)